Literature DB >> 10574705

TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.

E Piek1, A Moustakas, A Kurisaki, C H Heldin, P ten Dijke.   

Abstract

The capacities of different transforming growth factor-(beta) (TGF-(beta)) superfamily members to drive epithelial to mesenchymal transdifferentiation of the murine mammary epithelial cell line NMuMG were investigated. TGF-(beta)1, but not activin A or osteogenic protein-1 (OP-1)/bone morphogenetic protein-7 (BMP-7), was able to induce morphological transformation of NMuMG cells as shown by reorganisation of the actin cytoskeleton and relocalisation/downregulation of E-cadherin and (beta)-catenin, an effect that was abrogated by the more general serine/threonine kinase and protein kinase C inhibitor, staurosporine. TGF-(beta)1 bound to TGF-(beta) type I receptor (T(beta)R-I)/ALK-5 and T(beta)R-II, but not to activin type I receptor (ActR-I)/ALK-2. Activin A bound to ActR-IB/ALK-4 and ActR-II, and BMP-7 bound to ActR-I/ALK-2, BMP type I receptor (BMPR-I)/ALK-3, ActR-II and BMPR-II. TGF-(beta)1 and BMP-7 activated the Smad-binding element (SBE)(4) promoter with equal potency, whereas activin A had no effect. Transfection of constitutively active (CA)-ALK-4 activated the 3TP promoter to the same extent as TGF-(beta)1 and CA-ALK-5 indicating that activin signalling downstream of type I receptors was functional in NMuMG cells. In agreement with this, activin A induced low levels of plasminogen activator inhibitor I expression compared to the high induction by TGF-(beta)1. In contrast to activin A and BMP-7, TGF-(beta)1 strongly induced Smad2 phosphorylation. Consistent with these findings, TGF-(beta)1 induced the nuclear accumulation of Smad2 and/or Smad3. In addition, NMuMG cells transiently infected with adenoviral vectors expressing high level CA-ALK-5 exhibited full transdifferentiation. On the other hand, infections with low level CA-ALK-5, which alone did not result in transdifferentiation, together with Smad2 and Smad4, or with Smad3 and Smad4 led to transdifferentiation. In conclusion, TGF-(beta)1 signals potently and passes the activation threshold to evoke NMuMG cell transdifferentiation. The TGF-(beta) type I receptor (ALK-5) and its effector Smad proteins mediate the epithelial to mesenchymal transition. Activin A does not induce mesenchymal transformation, presumably because the number of activin receptors is limited, while BMP-7-initiated signalling cannot mediate transdifferentiation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10574705     DOI: 10.1242/jcs.112.24.4557

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  146 in total

Review 1.  TGF-beta signaling in mammary gland development and tumorigenesis.

Authors:  L M Wakefield; E Piek; E P Böttinger
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

2.  Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1.

Authors:  I Shin; A V Bakin; U Rodeck; A Brunet; C L Arteaga
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

Review 3.  Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal transdifferentiation: implications for fibrosis in kidney disease.

Authors:  P J Stahl; D Felsen
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

4.  TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses.

Authors:  Li Yu; Mindy C Hébert; Ying E Zhang
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

5.  Epithelial-to-mesenchymal transition induced by Freund's adjuvant treatment in rat mesothelial cells: a morphological and immunocytochemical study.

Authors:  Sándor Katz; Petra Balogh; Nándor Nagy; Anna L Kiss
Journal:  Pathol Oncol Res       Date:  2012-01-14       Impact factor: 3.201

Review 6.  Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-β-induced epithelial-mesenchymal transition.

Authors:  Samy Lamouille; Rik Derynck
Journal:  Cells Tissues Organs       Date:  2010-11-02       Impact factor: 2.481

7.  Pituitary tumor transforming gene induces epithelial to mesenchymal transition by regulation of Twist, Snail, Slug, and E-cadherin.

Authors:  Parag P Shah; Sham S Kakar
Journal:  Cancer Lett       Date:  2011-07-13       Impact factor: 8.679

8.  Zyxin is a transforming growth factor-β (TGF-β)/Smad3 target gene that regulates lung cancer cell motility via integrin α5β1.

Authors:  Nikica Mise; Rajkumar Savai; Haiying Yu; Johannes Schwarz; Naftali Kaminski; Oliver Eickelberg
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

9.  Sertad1 encodes a novel transcriptional co-activator of SMAD1 in mouse embryonic hearts.

Authors:  Yin Peng; Shaomin Zhao; Langying Song; Manyuan Wang; Kai Jiao
Journal:  Biochem Biophys Res Commun       Date:  2013-11-05       Impact factor: 3.575

Review 10.  Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.

Authors:  E-Jean Tan; Anna-Karin Olsson; Aristidis Moustakas
Journal:  Cell Adh Migr       Date:  2014-11-17       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.